Comparison between stem cell therapy and stem cell derived exosomes on induced multiple sclerosis in dogs

Area of Science:

• Neuroscience
• Regenerative Medicine
• Immunology

Background:

• Multiple sclerosis (MS) involves demyelination in the central nervous system, impacting oligodendrocytes.
• Stem cell therapy shows promise for MS by modulating immune responses and promoting remyelination.
• Stem cell-derived Exosomes offer therapeutic potential due to their molecular cargo and regenerative activities.

Purpose of the Study:

• To compare the efficacy of stem cells versus Exosomes in treating an experimental canine model of MS.
• To evaluate clinical, radiological, histopathological, and ultrastructural outcomes of these regenerative therapies.

Main Methods:

• An experimentally induced MS dog model was used.
• Intrathecal administration of either stem cells or Exosomes was performed.
• Comprehensive evaluation included clinical assessment, MRI, histopathology, electron microscopy, and CSF analysis.

Main Results:

• Both stem cells and Exosomes significantly improved clinical signs and reduced MS lesions compared to controls.
• Histopathology and electron microscopy confirmed substantial healing and remyelination in treated groups.
• Stem cell therapy exhibited superior efficacy in promoting remyelination over Exosome therapy.

Conclusions:

• Stem cells were more effective than Exosomes in promoting myelin regeneration in the MS model.
• Exosomes demonstrated safety and effectiveness as agents for myelin repair in MS.
• Both therapies hold potential for stimulating remyelination in demyelinating diseases like MS.